Cancer Research Horizons
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Infinitopes
21 Jan 2026
Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.
52North
6 Dec 2024
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
Cancer Research Horizons
More venture news
- 2 Jun 2026
Poindexter LabsPoindexter Labs lands a £2m seed round led by Episode 1 to supply frontier AI labs with expert STEM training data
SeedAI - 2 Jun 2026
ArchestraArchestra.AI announces a £7.5m seed round led by 20VC for open-source platform that lets enterprises connect AI agents to sensitive data
SeedDeveloper Tools - 1 Jun 2026
EdifyEdify lands a £3m seed round led by Calculus to help quick service restaurants automate ordering, forecasting and back-of-house operations
SeedHospitality
